Clinical Trial Update: Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Venlafaxine ER in children and adolescents with social anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Venlafaxine ER (venlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Social Anxiety Disorder | Phase 3 | Status: COMPLETED